Try our corporate solution for free!
(212) 419-8286

Global attitudes on COVID-19 vaccines developed in China 2020

A global survey on attitudes on coronavirus COVID-19 vaccinations found out that the trust in Chinese COVID-19 vaccines was relatively low across 17 surveyed countries or regions. As per the survey results generated in December 2020, about 57 percent of Danish respondents had a negative impression of the coronavirus vaccines produced in China. In comparison, a much smaller proportion of respondents from Indonesia, Mexico, and China shared the same perception.

Opinions on COVID-19 vaccines developed in China among international respondents as of December 2020, by country or region

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

In cooperation with
Release date

December 2020


Worldwide, China

Survey time period

7 to 20 December, 2020

Number of respondents

18,966 respondents

Method of interview

Online survey

Supplementary notes

Original survey question:
"Would you tend to think more positively or negatively about a COVID-19 vaccine if you saw that it was developed in China, or would it make no difference?"

The survey was conducted among about 2,000 respondents in the United States and the United Kingdom, around 500 respondents in Hong Kong, and slightly over 1,000 respondents in the remaining countries.

Percentages may not total 100 due to rounding.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus (COVID-19): vaccines and vaccination campaign"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.